2h
Zacks.com on MSNMYGN Stock Might Rise on Collaboration With CancerCAREMyriad Genetics entered into an agreement with CancerCARE for Life to provide individuals within the latter's network with access to the MyRisk Hereditary Cancer Test.
KBC Group NV raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 132.8% in the fourth quarter, ...
GeneDx has a big market in mind for its genetic testing: every newborn baby. The 24-year-old-company wants to make the testing common at birth. The goal: Identify potential diseases or conditions so ...
What makes the human brain unique? A Yale study unlocks new insights into genetic changes that shaped our evolution.
12h
News Medical on MSNAI approach reveals possible fusion of rare diseases in COVID-19 origins In A Landmark Dis...Despite extensive research, the origins of COVID-19 remain elusive. In a new study published in the KeAi journal Advances in Biomarker Sciences and Technology (ABST), an AI-driven approach was adopted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results